Immunoprecise Antibodies (IPA.V) subsidiary Biostrand and VLAIO—Flanders Innovation and Entrepreneurship—the research fund of the Flemish regional government in Belgium—have greed on a 460,000-euro round of grant financing. This award…
IPA.V
IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of…
Before we start, let’s give a big round of applause to Immunoprecise Antibodies Ltd and all its staff and its management. They are headed to the big leagues, ladies…
Immunoprecise Antibodies (IPA.V) and research institute for artificial intelligence and machine learning, Mila Institute, inked a research partnership today, according to a press release. The two companies will collaborate…
Immunoprecise Antibodies (IPA.V) subsidiary, IPA Europe, invested in its B-Cell Select platform at its research division in Oss, the Netherlands, enabled by prior investments in equipment to automate and…
You know what grinds my gears? The fact that investors will happily speculate on Tesla (TSLA.NYSE) stock because they think they understand the automobile market, but won’t attempt to…